1968
DOI: 10.1016/s0140-6736(68)92510-5
|View full text |Cite
|
Sign up to set email alerts
|

Sphingolipids and Phospholipids of Myelin in Multiple Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

1971
1971
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(25 citation statements)
references
References 5 publications
2
23
0
Order By: Relevance
“…In these previous studies, serine and ino sitol phosphatides were not separated and concentrations were given for the sum of both glycerophosphatides. In this study we were able to sepa rate these two phospholipid classes by two-dimensional thin-layer chro matography and to show that the molar ratio of SPG:IPG is approximately 3:1 for normal human myelin ( [6] and Cumings and Goodwin [5] for the myelin of three cases of MS, and those of G erstl et al [11] for two other cases. These investigators ob tained less cerebroside for MS than for normal myelin, with a concomi tant increase of sulfatide.…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…In these previous studies, serine and ino sitol phosphatides were not separated and concentrations were given for the sum of both glycerophosphatides. In this study we were able to sepa rate these two phospholipid classes by two-dimensional thin-layer chro matography and to show that the molar ratio of SPG:IPG is approximately 3:1 for normal human myelin ( [6] and Cumings and Goodwin [5] for the myelin of three cases of MS, and those of G erstl et al [11] for two other cases. These investigators ob tained less cerebroside for MS than for normal myelin, with a concomi tant increase of sulfatide.…”
Section: Discussionmentioning
confidence: 81%
“…Several investigators have found depletion of lipids and changes in the fatty acid pattern of individual lipid classes in areas of apparently normal white matter in multiple sclerosis (MS) and other demyelinating diseases [1,5,10,22). These observations suggest that patients with MS might have abnormalities of brain lipid metabolism (for instance an inadequacy Abbreviations: Fatty acids are denoted by chain length: number of double bonds; n-6 denotes the first double bond six carbons from the methyl group of the fatty acid chain.…”
Section: Myelin Multiple Sclerosis Phosphoglycerides Galactolipids Famentioning
confidence: 99%
“…Earlier studies of MS myelin lipid composition have reported variable results (Cumings, 1953;Gerstl et al, 1961;Davidson and Wajda, 1962; Cum- ings and Goodwin, 1968;Clausen and Hansen, 1970;Gerstl et al, 1970;Alling et al, 1971;Rinne et al, 1972;Gopfert et al, 1980;Husted et al, 1994). This is due not only to technological limitations in the analysis of the complicated lipid mixture from myelin, but also to the random occurrence of myelin changes throughout the brain and spinal cord with regard to both position and time in MS.…”
Section: Discussionmentioning
confidence: 99%
“…This finding does not, however, rule out the possibility that the normal metabolism of myelin sheath is disturbed before any lysosomal changes are seen by electron microscopy [3,19,34], That this may be the case is suggested by chemical studies, which show that the different compo nents of myelin are affected at different stages of the disease [10,15,16,30], If myelin were degraded solely by the peeling-off process and subsequent 'bulk' digestion in the lysosomes, one would expect that dif ferent constituents would be lost approximately in the same proportion as they are present normal myelin. One possibility which must be taken into account in the degradation of myelin is the fact that purified myelin fractions both from CNS and from PNC contain proteinase activity as an integral of the membrane [1,18,21].…”
Section: Lysosomal Alterations and Their Relationship To Demyelinationmentioning
confidence: 93%